发明名称 Treatment regimen for N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors
摘要 The present invention relates to methods and compositions for treating diseases. More specifically, the present invention relates to the administration of multiple drugs as part of a treatment of disease. Specific embodiments of the invention relate to a treatment regimen for neuroblastomas and other N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors, comprising administering multiple therapeutic compounds like DFMO, SAM486A, a verinoid and a cytotoxic drug and placing the patient on a low polyamine diet and/or providing the patient with a polyamine limiting dietary supplement.
申请公布号 US9072778(B2) 申请公布日期 2015.07.07
申请号 US200612158661 申请日期 2006.12.20
申请人 UNIVERSITY OF HAWAII 发明人 Bachmann Andre S.
分类号 A61K31/198;A61K31/365;A61K31/203;A61K45/06;A61K31/167 主分类号 A61K31/198
代理机构 Davis Wright Tremaine LLP 代理人 Davis Wright Tremaine LLP
主权项 1. A method of treating N-MYC amplified and overexpressed tumors in a mammal, comprising: administering to said mammal a composition comprising therapeutically effective amounts of alpha-difluoromethylornithine (DFMO) and etoposide, wherein administration of the composition results in inhibition of abnormal cell proliferation, wherein the N-MYC amplified and overexpressed tumor is a neuroblastoma tumor.
地址 Honolulu HI US